AHFS May 2024 Update

This update contains 5 new monographs and 26 revised monographs.

New monographs: Berdazimer Sodium; Birch Triterpenes; Brincidofovir; Cefepime Hydrochloride and Enmetazobactam; Lifileucel.

Revised monographs: Abrocitinib; Acalabrutinib; Alpelisib; Amisulpride; Brigatinib; Cabotegravir and Rilpivirine; Cabotegravir Sodium; COVID-19 Vaccine, Adjuvanted (Novavax); COVID-19 Vaccine, mRNA (Moderna); COVID-19 Vaccine, mRNA (Pfizer-BioNTech); Daprodustat; Dasatinib; Dolutegravir Sodium; Faricimab-svoa; Givosiran Sodium; lamiVUDine; Letermovir; Maribavir; Monomethyl Fumarate; Mosunetuzumab-axgb; Odevixibat; Pirtobrutinib; Sarilumab; Tenofovir Alafenamide Fumarate; Valbenazine Tosylate; Vericiguat.